Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics

Mangalam AK^1,2*, Poisson LM^3,4, Nemutlu E⁵, Datta I^3,4, Denic A², Dzeja P⁶, Rodriguez M^1,2, Rattan R⁷ and Giri S⁸

¹Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA

²Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA

³Center for Bioinformatics, Henry Ford Health System, Detroit, MI 48202, USA

⁴Department of Public Health Sciences, Henry Ford Health System, Detroit, MI 48202, USA

⁵Department of Analytical Chemistry, Faculty of Pharmacy, University of Hacettepe, Ankara, Turkey

⁶Division of Cardiovascular Diseases, Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA

⁷Division of Gynecology Oncology, Department of Womens Health Services, Henry FordHealth System, Detroit, MI 48202, USA

⁸Department of Neurology, Henry Ford Health System, Detroit MI48202, USA

^*Corresponding Author: Mangalam AK, Research Division, Department of Immunology and Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA Email: